Skip to main content
SpringerLink
Log in

Differing diagnoses for European and US patents

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

  • 7 Altmetric

Medical diagnostic patent applications in the United States and Europe face diverging fates following the Supreme Court's decision in Mayo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Fate of diagnostic patent applications.

References

  1. Bayh–Dole Act (Pub. L. 96-517, December 12, 1980).

  2. 35 U.S.C. § 101.

  3. US Const. Art. I, § 8, cl. 8.

  4. Mayo Collaborative Services v. Prometheus Laboratories, Inc. 132 S. Ct. 1289 (2012).

  5. Ledford, H. Nature 536, 382 (2016).

    Article  CAS  Google Scholar 

  6. US patent 6,258,540 B1 (10 July 2001).

  7. Ariosa Diagnostics, Inc. v. Sequenom, Inc. 788 F.3d 1371 (Fed. Cir. 2015).

  8. European Patent Convention Article 52(4) (2007).

Download references

Acknowledgements

We thank C.R. Macedo for his comments on an earlier version of the manuscript. The views expressed herein are those of the authors and do not necessarily represent those of Amster, Rothstein & Ebenstein, LLP, or its clients. Nothing in this article is to be construed as legal advice or as a substitute for legal advice.

Author information

Authors and Affiliations

  1. Brian Amos and Alan D. Miller are at Amster, Rothstein & Ebenstein, LLP, New York, New York, USA.,

    Brian Amos & Alan D Miller

Authors
  1. Brian Amos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan D Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan D Miller.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amos, B., Miller, A. Differing diagnoses for European and US patents. Nat Biotechnol 35, 334–335 (2017). https://doi.org/10.1038/nbt.3839

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3839

  • Springer Nature America, Inc.

Search

Navigation